• 11/30/2024

Wall Street Predicted a Blockbuster. Now the Drug May Be Withdrawn.

Wall Street Journal

Amylyx’s ALS drug failed a late-stage trial, raising questions about the future of the drug and the company itself.

https://www.wsj.com/articles/wall-street-predicted-a-blockbuster-now-the-drug-may-be-withdrawn-f23570ee